Press Release

Nasal Drug Delivery Systems Market Expected to Reach USD 98.40 billion by 2030

The Global Nasal Drug Delivery Systems Market size was valued at USD 65.06 billion in 2023 and is projected to reach USD 98.40 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 5.9% during the forecast period, i.e., 2024-30, cites MarkNtel Advisors in the recent research report. The key factors that can be attributed to the market growth include augmenting viral infections due to seasonal changes, migraine owing to sedentary lifestyles, etc.

Many individuals throughout the world have been developing migraine headaches as a result of long working hours, consuming too much caffeine, drinking alcohol, etc. These individuals demand immediate relief from pain to carry on with their daily and routine activities and oral drugs have not been very effective in providing faster response. Due to this, the focus has shifted to taking migraine medications through nasal routes via the employment of nasal drug delivery systems. Subsequently, the overall market for Nasal Drug Delivery Systems has been experiencing positive growth trends.

Further, parents around the globe are getting concerned about the issue of nasal congestion their babies have been facing as a result of seasonal changes, viral infections, and pollution. To provide comfort, they have been taking the help of nasal drug delivery systems for administering nasal saline solutions that tend to be safer and provide immediate relief to the babies. As a result of this, the market for Nasal Drug Delivery Systems has been expanding in market size.

Also, many children & adults have been reported to have faced the instance of anaphylaxis shock as a result of consuming foods such as peanuts, cow’s milk, etc., taking medications such as non-steroidal anti-inflammatories (NSAIDs), and antibiotics among others as well as due to insect stings. As it could be life-threatening to wait for oral medications to work or employ injections, the adoption of nasal drug delivery systems to provide urgent care to patients has witnessed a rise. The market thereby has been registering significant growth trends.

Moreover, as the heightened proportion of elderly patients has been suffering from central nervous system (CNS) disorders, the demand for nasal drug delivery systems has been increasing. This is because the patients become agitated or aggressive as the disease gets worse and it becomes problematic to feed them oral medications or administer injections. Therefore, considering the aforementioned factors Global Market for Nasal Drug Delivery Systems has been experiencing positive growth trends, further states the research report, “Global Nasal Drug Delivery Systems Market Analysis, 2024.”

Global Nasal Drug Delivery Systems Market Segmentation Analysis

Unit Dose Category Held the Considerable Market Share of the Global Nasal Drug Delivery Systems Market

Based on the system type segment, the market is further bifurcated into, Unit Dose, Bi Dose, and Multi Dose. Of them, the unit dose category expects to hold a considerable market share of the Global Nasal Drug Delivery Systems Market. Globally, the population of fitness and sports enthusiasts has increased tremendously. However, the incidences of sports injuries & fractures accompanied by tremendous pain have also soared astronomically. Unit dose systems offer precise & safer nasal drug administration which is highly desirable in the case of children.  Especially, in the age group lower than 15 the tendency to overpower the injuries via medication using a nasal drug delivery system has been soaring.

Subsequently, the market has been expanding for unit-dose drug delivery systems. Further, as cases of life-threatening hypoglycemia have been reported in increased numbers in older diabetic patients, the demand for unit-dose nasal drug delivery systems to provide urgent treatment to the patients has been increasing. As a result, the category’s market size has been expanding globally.

North America Expects to Held a Prominent Market Share of the Global Nasal Drug Delivery Systems Market

North America held a significant market share of the Global Nasal Drug Delivery Systems Market, among all the regions. This has been because of the cases of opioid use disorder being reported in heightened numbers which require urgent & immediate treatment responses, possible via nasal drug delivery systems. Further, the rates of Alzheimer’s & Parkinson’s Disease have been inclining in the region at alarming rates. The patients who are largely elderly & their families find it hard to have oral medications and thereby have been shifting towards nasal drug administration. Subsequently, the demand for nasal drug delivery systems has been elevating in the region, positively impacting the overall North American nasal drug delivery systems Market. Moreover, as cases of severe depression have been observed in significant numbers in regional countries like the US & Canada, the adoption of nasal drug delivery systems to get immediate relief from stress & anxiety has been on the rise.

Competitive Landscape

With strategic initiatives, such as mergers, collaborations, and acquisitions, the leading market players, including Becton, Dickinson and Company, 3M, Zeteo Biomedical LLC, Nemera, AptarGroup, Inc., MetP Pharma AG, Bespak Limited (Recipharm), Teleflex Incorporated, Doctor Pack India Private Limited, Hovione, and Others are looking forward to strengthening their market position.

Key Questions Answered in the Research Report

1. What are the industry’s overall statistics or estimates (Overview, Size- By Value, Forecast Numbers, Segmentation, Shares)?
2. What are the trends influencing the current scenario of the market?
3. What key factors would propel and impede the industry across the regions?
4. How has the industry been evolving in terms of geography & product adoption?
5. How has the competition been shaping across various regions?
6. How has the buying behavior, customer inclination, and expectations from product manufacturers been evolving during 2019-30?
7. Who are the key competitors, and what strategic partnerships or ventures are they coming up with to stay afloat during the projected time frame?